Proposed Registration Decision PRD2020-09, Fluxapyroxad and Xzemplar

This summary describes the key points of the evaluation, while the Science Evaluation of Proposed Registration Decision PRD2020-09, Fluxapyroxad and Xzemplar provides detailed technical information on the human health, environmental and value assessments of fluxapyroxad and Xzemplar.

Données et ressources

Info additionnelle

Champ Valeur
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward